Literature DB >> 31347098

Dabigatran-induced anticoagulant-related nephropathy with undiagnosed IgA nephropathy in a patient with normal baseline renal function.

Masaki Ikeda1, Mari Tanaka2, Saeko Shimoda2, Hirona Saita2, Seira Nishikawa2, Hiroki Shimada2, Keisuke Taniguchi2, Koichiro Hagihara2, Sachio Iwanari2, Hiroya Takeoka2.   

Abstract

Occasionally, over-anticoagulation with warfarin induces acute kidney injury (AKI) characterized by glomerular hemorrhage with tubular obstruction by red blood cell casts, which is widely acknowledged as warfarin-related nephropathy. Owing to extensive use of direct oral anticoagulants, similar AKI cases have been reported among patients treated with dabigatran. Dabigatran is primarily excreted by the kidneys; thus, renal impairment is one of the risk factors for dabigatran-induced bleeding complications. Nevertheless, risk factors for dabigatran-induced anticoagulant-related nephropathy (ARN) remain partially clarified. Here, we report a histologically established case of dabigatran-induced ARN with undiagnosed IgA nephropathy in a patient with normal baseline renal function. In addition, we summarize previously published cases of biopsy-proven, dabigatran-related ARN. A 67-year-old female with normal preexisting renal function developed macrohematuria and AKI. She had been treated with dabigatran for deep vein thrombosis. A renal biopsy diagnosed ARN with inactive IgA nephropathy. After dabigatran withdrawal, her macrohematuria and renal function improved. This report demonstrates that ARN could occur in patients with normal baseline renal function. Our case and prior reports suggest that IgA nephropathy could be a risk factor for dabigatran-induced ARN.

Entities:  

Keywords:  Acute kidney injury; Anticoagulant-related nephropathy; Dabigatran; Direct oral anticoagulants; IgA nephropathy; Warfarin-related nephropathy

Mesh:

Substances:

Year:  2019        PMID: 31347098      PMCID: PMC6820621          DOI: 10.1007/s13730-019-00410-7

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  21 in total

1.  Anticoagulant-related nephropathy in a patient with IgA nephropathy.

Authors:  Mário Góis; Ariana Azevedo; Fernanda Carvalho; Fernando Nolasco
Journal:  BMJ Case Rep       Date:  2017-02-20

Review 2.  Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity.

Authors:  Rigas G Kalaitzidis; Anila Duni; Georgios Liapis; Olga Balafa; Sofia Xiromeriti; Paulos Karolos Rapsomanikis; Moses S Elisaf
Journal:  Int Urol Nephrol       Date:  2017-02-04       Impact factor: 2.370

Review 3.  Proteinuria in adults: a diagnostic approach.

Authors:  M F Carroll; J L Temte
Journal:  Am Fam Physician       Date:  2000-09-15       Impact factor: 3.292

Review 4.  AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences.

Authors:  Juan Antonio Moreno; Catalina Martín-Cleary; Eduardo Gutiérrez; Oscar Toldos; Luis Miguel Blanco-Colio; Manuel Praga; Alberto Ortiz; Jesús Egido
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-17       Impact factor: 8.237

5.  Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

Authors:  Sam Schulman; Clive Kearon; Ajay K Kakkar; Patrick Mismetti; Sebastian Schellong; Henry Eriksson; David Baanstra; Janet Schnee; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

6.  Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases.

Authors:  Sergey V Brodsky; Anjali Satoskar; Jun Chen; Gyongyi Nadasdy; Jeremiah W Eagen; Mirza Hamirani; Lee Hebert; Edward Calomeni; Tibor Nadasdy
Journal:  Am J Kidney Dis       Date:  2009-07-04       Impact factor: 8.860

7.  Management and outcomes of major bleeding during treatment with dabigatran or warfarin.

Authors:  Ammar Majeed; Hun-Gyu Hwang; Stuart J Connolly; John W Eikelboom; Michael D Ezekowitz; Lars Wallentin; Martina Brueckmann; Mandy Fraessdorf; Salim Yusuf; Sam Schulman
Journal:  Circulation       Date:  2013-09-30       Impact factor: 29.690

8.  N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy.

Authors:  Kyle Ware; Zahida Qamri; Ayhan Ozcan; Anjali A Satoskar; Gyongyi Nadasdy; Brad H Rovin; Lee A Hebert; Tibor Nadasdy; Sergey V Brodsky
Journal:  Am J Physiol Renal Physiol       Date:  2013-04-10

9.  The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.

Authors:  Joachim Stangier; Karin Rathgen; Hildegard Stähle; Dietmar Gansser; Willy Roth
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

10.  Dabigatran-Related Nephropathy in a Patient with Undiagnosed IgA Nephropathy.

Authors:  Rachele Escoli; Paulo Santos; Sequeira Andrade; Fernanda Carvalho
Journal:  Case Rep Nephrol       Date:  2015-08-05
View more
  3 in total

1.  The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation.

Authors:  Ziv Harel; Eric McArthur; Nivethika Jeyakumar; Manish M Sood; Amit X Garg; Samuel A Silver; Paul Dorian; Daniel Blum; William Beaubien-Souligny; Andrew T Yan; Sunil V Badve; Brendan Smyth; Min Jun; Racquel Jandoc; Abhijat Kitchlu; Ron Wald
Journal:  Clin J Am Soc Nephrol       Date:  2021-08-18       Impact factor: 10.614

2.  IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy.

Authors:  Hernando Trujillo; Justo Sandino; Teresa Cavero; Fernando Caravaca-Fontán; Eduardo Gutiérrez; Ángel M Sevillano; Amir Shabaka; Gema Fernández-Juárez; Pablo Rodríguez Doyágüez; Rocío Gimena Muñoz; Leonardo Calle García; Virginia Cabello; José Manuel Muñoz-Terol; Ana García Santiago; Oscar Toldos; Juan Antonio Moreno; Manuel Praga
Journal:  Kidney Int Rep       Date:  2022-01-19

3.  Warfarin: A double-edged sword.

Authors:  Prabhakar Yadav; Sonal Yadav; Saurabh Pathak
Journal:  J Family Med Prim Care       Date:  2019-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.